Beijing-Geneplus Technology Limited
吉因加
Beijing-Geneplus Technology Limited
Biotech/Healthcare
Geneplus, founded in Beijing in April 2015, specializes in cancer genomic testing. It has independently developed core technologies including ER-Seq, mTBI, and mClone, establishing a minimally invasive, precise, and dynamic ctDNA testing system.
Latest round: Series D (2025)
Source: ChinaBulls — chinabulls.com
Last updated 2025-12-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.